WO2002062901A1 - Dental and medical polymer composites and compositions - Google Patents

Dental and medical polymer composites and compositions Download PDF

Info

Publication number
WO2002062901A1
WO2002062901A1 PCT/FI2002/000087 FI0200087W WO02062901A1 WO 2002062901 A1 WO2002062901 A1 WO 2002062901A1 FI 0200087 W FI0200087 W FI 0200087W WO 02062901 A1 WO02062901 A1 WO 02062901A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
nanofiuer
polymer composite
dendrimer
multifunctional polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FI2002/000087
Other languages
English (en)
French (fr)
Other versions
WO2002062901A8 (en
Inventor
Pekka Vallittu
Lippo Lassila
Mikael Skrifvars
Eeva Viljanen
Antti Yli-Urpo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20010222A external-priority patent/FI20010222A0/fi
Priority to DE60228823T priority Critical patent/DE60228823D1/de
Application filed by Individual filed Critical Individual
Priority to PL365346A priority patent/PL204442B1/pl
Priority to CA2437622A priority patent/CA2437622C/en
Priority to BRPI0207480-0A priority patent/BR0207480B1/pt
Priority to US10/467,080 priority patent/US7354969B2/en
Priority to CNB028059034A priority patent/CN100393813C/zh
Priority to AU2002231823A priority patent/AU2002231823B2/en
Priority to KR1020037010390A priority patent/KR100893126B1/ko
Priority to JP2002563245A priority patent/JP3971307B2/ja
Priority to EP02711891A priority patent/EP1368430B1/en
Publication of WO2002062901A1 publication Critical patent/WO2002062901A1/en
Anticipated expiration legal-status Critical
Publication of WO2002062901A8 publication Critical patent/WO2002062901A8/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/005Reinforced macromolecular compounds with nanosized materials, e.g. nanoparticles, nanofibres, nanotubes, nanowires, nanorods or nanolayered materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/20Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • C08L101/005Dendritic macromolecules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Definitions

  • the invention relates to polymerisable multifunctional polymer composites and compositions, which are suitable for dental and medical applications, such as dental prostheses, filling materials, implants and the like. It also relates to a method for the manufacture of such multifunctional polymer composites and compositions, and to the use of said multifunctional polymer composites and compositions in dental and medical applications.
  • Polymeric particulate filler composites such as those made from 2,2 ⁇ bis-4-(2- hydroxy-3-methacryloxy)phenyl propane (BisGMA) - triethylene glycol dimethacrylate (TEGDMA) with inorganic fillers, are commonly used as tooth filling materials or in veneering of dental bridges.
  • BisGMA-TEGDMA monomer systems are their high volumetric shrinlcage in polymerisation, inadequate wear resistance of the material and poor adhesive properties as substrates after being polymerised and aged. The latter shortcoming has made the repair of old composite fillings difficult by using dental adhesive techniques.
  • laminating and veneering of a composite dental appliance is influenced negatively by poor adhesive properties of composite laminate layers.
  • the problem of volumetric shrinkage relates also to dental adhesives, causing the polymerised adhesive film to detach from tooth structures and dentin tubulus.
  • fibre-reinforced composites in dental applications is based on mono- or dimethacrylate monomer systems to form a copolymer and/or a multiphase polymer matrix to the FRC.
  • Adhering of a particulate filler composite to the FRC substrate is of great importance in clinical success of FRC restorations.
  • the highly cross-linked dimethacrylate polymer matrix of FRCs has been shown to be an inadequate adhesive substrate for new polymer matrices when restoring the FRC.
  • a multiphase polymer matrix allowing formation of inte enetrating polymer network (1PN) bonding, has been introduced to the FRC.
  • these multiphase polymer matrices have the same problems with inadequate adhesive substrate properties.
  • the inadequate wear resistance of conventional dental filling composites relates to particle size, sizing of filler particles by coupling agents and type of the polymer matrix.
  • Hyperbranched polymers (HBP) and dendritic polymers are three-dimensional, highly ordered oligomeric and polymeric compounds which are synthesised starting from small initiator molecules by a reaction sequence which is continually repeated. These compounds differ significantly from conventional polymers used in dental materials.
  • HBPs and dendritic polymers are compact spherical molecules with many branches. Due to the spherical, highly branched structure, the HBPs and the dendritic polymers have a high number of functional end- groups located at the sphere of the structure, while a linear, unbranched polymer has only two functional end-groups.
  • HBPs and dendritic polymers are well known in the literature.
  • US 5 418 301 discloses a dendritic macromolecule of polyester type having a central initiator molecule or initiator polymer with one or more reactive hydroxyl groups (A).
  • the groups (A) are under formation of an initial tree structure, bonded to reactive car- boxyl groups (B) of a monomeric chain extender having the two reactive groups (A) and (B).
  • the tree structure is optionally extended and further branched from the initiator molecule or initiator polymer by addition of further molecules of a monomeric chain extender by means of bonding between the reactive groups (A) and (B) thereof and it is thereafter optionally further extended by reaction with a chain stopper.
  • US 5 834 118 teaches a hyperbranched polyester of a polyol with 3 to 10 reactive hydroxyl groups and an aromatic polycarboxylic anhydride with 2 to 4 carboxyl groups, each hydroxyl group of the polyol forming an ester linkage with one anhydride group of the polycarboxylic anhydride, and further glycidyl (meth)acrylate or allyl glycidyl ether forming ester linkages with the remaining carboxyl groups of the anhydride and free hydroxyl groups. Further, in the hyperbranched polyester, (meth)acrylic anhydride and/or an aliphatic carboxylic anhydride form ester linkages with the free hydroxyl groups.
  • a hyperbranched polymer having at least 6 terminal hydroxyl or carboxyl groups and a Carothers gel point lower than 1 is disclosed in WO 93/18079.
  • the HBP is comprised of a nucleus and polyol and polycarboxy residues.
  • the hyperbranched polymer is obtainable by starting with a nucleus compound containing at least one hydroxyl group as the nucleus and reacting it with a compound containing at least one anhydride group, then the resulting first generation acid-terminated addition product is reacted with a compound containing at least one epoxy group.
  • the resulting first generation hydroxyl-te ⁇ ninated addition product is reacted with a compound containing at least one anhydride group, then the resulting second generation acid-terminated addition product is reacted with a compound containing at least one epoxy group resulting in a second generation hydroxyl-terminated addition product.
  • At least one generation monomers are used which have at least one functional group besides the anhydride group or epoxy group.
  • US 5 886 064 discloses a granular, polymerisable composition which contains at least one polymerisable monomer and/or oligomer and a polymerisation initiator and optionally an accelerator and at least 70 wt % of a filler with a particle size of 0,1 - 1,0 ⁇ m, and additionally 0.5 to 28 wt % of a dendrimer.
  • Suitable dendrimers are propyleneimine dendrimers, polyether/polythioether dendrimers, polyester dendrimers, polyphenyleneamide dendrimers and polyphenylene ester dendrimers.
  • the dendrimers have polymerisable terminal groups which are (meth)acrylic, allyl, styryl, vinyl, vinyloxy and/or vinylamine groups. Said composition becomes flowable under compressive or shear stress.
  • the composition can be packed in a similar manner like amalgam and it is suitable as a dental material or for the production of a dental material.
  • the high filler content with optimized polymerisable monomer/oligomer content ensures the formation of a ho- mogeneous granular system.
  • the rigidity of the construction corresponding to the modulus of the bone plays an important role in diminishing the stress formation to the inter-phase between the implant and bone.
  • the currently used endos- seus implants are typically made of titanium alloys or cobalt-chromium alloys with a flexural modulus considerably higher than that of bone. The mismatch in these properties can explain partly the loosening of e.g. hip prostheses after use for some years.
  • the FRC comprises a group of materials with mechanical properties which can be tailor-made corresponding to the properties of bone.
  • the FRC made of high rigidity fibres of silica, carbon graphite or glass, increases the modulus of the material.
  • the polymer matrix of FRC is also responsible in tailoring of the mechanical properties of FRC.
  • the dimethacrylate based polymers e.g. BisGMA-TEGDMA systems
  • result in relatively low flexural modulus which can retain the modulus of the FRC at a low level compared to that of cortical bone.
  • An object of the invention is to provide polymerisable, multifunctional polymer composites and compositions suitable for dental and medical applications, particularly for applications like filling materials, dental technological constructions, dental and orthopedical implants, other medical implants and endoprostheses, tis- sue guiding materials, cell and tissue culture matrix, orthopedical prostheses, drug releasing matrix materials and the like.
  • a further object of the invention is to provide a method for the manufacture of said polymerisable multifunctional polymer composites and compositions and polymerisable multifunctional polymer composite prepregs.
  • a still further object of the invention is the use of said polymerisable multifunctional polymer composites and compositions and polymerisable multifunctional polymer composite prepregs in dental and medical applications.
  • polymerisable multifunctional polymer composites and compositions comprising 1) a reactive dendrimer or a combination of reactive dendrimers with various molecular weights, 2) a reactive solvent or a combination of reactive solvents, and 3) a nanofiller or a combination of nanofillers of various size, pref- erably the particle size being ⁇ 0.1 ⁇ m, are especially suitable for dental and medical applications.
  • the polymerisable multifunctional polymer composite or composition comprises a) 30 - 99 wt% monomers comprising 30 - 99 wt%, preferably 50 - 90 wt% and particularly preferably 60 - 80 wt% of a dendrimer or a combination of dendrimers and 1 - 70 wt%, preferably 1 - 50 wt% and particularly preferably 1 - 30 wt% of a reactive solvent or a combination of reactive solvents, and b) 0.1 -70 wt%, preferably 30 - 70 wt% and particularly preferably 50 - 70 wt% of a nano- filler or a combination of nanofillers.
  • the reactive dendrimer is selected from the group consisting of acrylate or meth- acrylate functionalised multifunctional cross-linkers, such as those described in the patent US 5 834 118.
  • Suitable dendrimers and hyperbranched polymers are obtained by reacting an initiator molecule having one or more hydroxyl groups with aromatic polycarboxylic compounds in a selective manner to obtain a or- dered structure.
  • Dendrimers and hyperbranched polymers obtained by the reaction of amino-containing initiator molecules with vinyl cyanides can also be used, as well as dendrimers and hyperbranched polymers obtained from the reaction between an initiator molecule having one or more hydroxyl groups and a chain extender having one hydroxyl groups and at last two carboxyl group.
  • Dendrimers and hyperbranched polymers having a spherical structure are preferred.
  • dendrimers and hyperbranched polymers of the 2 n or higher genereration are particularly suitable. The generation is defined as the number of consecutive reactions necessary to obtain the desired structure.
  • the dendrimers and hyperbranched polymers have terminal end groups, which are reactive and can take part in a chemical reaction. Possible terminal groups are hydroxyl, carboxyl or amino groups. Dendrimers and hyperbranched polymers with combinations of these groups are also possible. The terminal groups are further reacted with organic re- actants, so that the end group is converted to a reactive, polymerizable terminal group.
  • suitable polymerizable terminal groups in the dendrimers are acrylic, methacrylic, allylic or vinylic group, of which the preferred ones are allylic, methacrylic and acrylic groups.
  • Particularly preferable dendrimers are methacrylate terminated dendrimers.
  • dendrimers and hyperbranched polymers having reactive polymerizable groups is performed according to the principles of commonly known re- actions, between suitable monomeric reagents and the dendrimers, respectively the hyperbranched polymers.
  • Particularly preferred monomeric reagents are methacrylic acid chloride, methacrylic acid and methacrylic anhydride for the reaction with hydroxyl terminal dendrimers and hyperbranched polymers, 2- hydroxy ethyl methacrylate, allyl glycidylether, glycidyl acrylate and glycidyl- methacrylate for the reaction with carboxyl terminated dendrimers and hyperbranched polymers, acryloyloxy ethyl methacrylate for the reaction with amino containing dendrimers.
  • the nanofiUer which acts as a filling substance is an organic, an inorganic or an organic-inorganic-hybrid compound.
  • the nanofiUer is a solid powder at room temperature with a particle size of less than 0.1 ⁇ m.
  • the organic nanofiUer is selected from a group consisting of a polymer chain, a cluster of polymer chains, a co-polymer of said polymers and the like, such as polymerized alkyl acrylate and/or alkyl methacrylate monomers.
  • the organic nanofiUer is a cluster of polymer chains of polymethyl methacrylate (PMMA) or a cluster of polymer chains of polyethyleneglykol dimethacrylate (PEG DMA).
  • the organic nanofiUer can be in the form of polymerised solid particles, which are partly dissolved by the dendrimer and the reactive solvent.
  • Organic nanofiUer polymers consisting of monomers such as alkyl methacrylates and alkyl dimethacrylates, alkyl acrylates and alkyl diacrylates and preferably methyl methacrylate, mixed with reactive solvents, form after polymerisation nanofillers, like clusters of polymer chains, between the dendrimers.
  • the inorganic nanofiUer is selected from a group consisting of particles of aluminium oxide, silicates, glass fillers such as quartz and barium glass fillers, ceramic materials, silica gel (Si-gel) and titanium gel (Ti-gel).
  • Preferable inorganic nanofillers with regard to improved wear resistance of dental filling composites, are quartz and barium glass fillers.
  • the organic-inorganic-hybrid nanofiUer is selected from the group consisting of polysilsesquioxanes, known as POSS monomers.
  • the reactive solvent acts in the forming of the organic nanofiUer phase in polym- erisation, as a carrier for the organic or inorganic nanofiUer, and in the lowering of the viscosity of the dendrimer to obtain a useable resin.
  • the reactive solvent suitably an acrylate or methacrylate monomer such as methyl methacrylate, ethyl methacrylate, butyl methacrylate, propyl methacrylate and preferably methyl methacrylate, after being polymerised, forms also an organic nanofiUer.
  • composition or composite may optionally comprise reinforcement, such as glass fibre, carbon graphite fibre and polyethylene fibre, and other suitable addi- tivesknown in the art, such as plasticizers, antioxidants, polymerisation inhibitors, accelerators and catalysts if required.
  • reinforcement such as glass fibre, carbon graphite fibre and polyethylene fibre
  • suitable addi- tives such as plasticizers, antioxidants, polymerisation inhibitors, accelerators and catalysts if required.
  • Drug substances and anti-microbiological agents may also be incorporated into the polymer composition or composite, preferably in combination with Si-gel and Ti-gel fillers.
  • the method for the manufacture of a polymerisable multifunctional polymer composite or composition comprises following steps:
  • a monomer mixture is prepared.
  • the monomer mixture contains 30-99 wt%, preferably 50 - 90 wt% and particularly preferably 60 - 80 wt% of a dendrimer or a mixture of dendrimers, and 1-70 wt%, preferably 1 - 50 wt% and particularly preferably 1 - 30 wt% of a reactive solvent or a mixture of reactive solvents.
  • 0.1-70 wt%, preferably 30 - 70 wt% and particularly preferably 50 - 70 wt% of an inorganic an organic or an organic-inorganic-hybrid nanofiUer or a combination of said fillers is added.
  • the reactive dendrimer(s) is mixed with the reactive solvent(s) and the nanofiUer(s) is then added.
  • the compo- nents are mixed at room temperature or at a slightly elevated temperature of 20 - 50°C using any suitable mixing technique.
  • a polymerisation initiator and an op- tional catalyst are added, 0.1-3 wt% of each, and other optional additives.
  • the mixture is stored at a cool place, preferably at or below a temperature of 10 °C and in dark, in a tightly closed container in order to avoid evaporation of volatile components and polymerisation of the mixture.
  • the mixture is left to stand for up to one day to ensure complete solvation and mixing of all components.
  • a gel-like dendrimer mixture is obtained with a viscosity, which is workable in the planned application.
  • the obtained gel-like dendrimer mixture can be mixed with 60 - 98 wt% of an inert solvent, such as an alcohol, ketone, alkane or the like, and preferable ones are ethanol, methanol, acetone, hexane, cyclohexane or tetrahydrofuran, in order to obtain a curable dental adhesive or a dental coating.
  • an inert solvent such as an alcohol, ketone, alkane or the like
  • preferable ones are ethanol, methanol, acetone, hexane, cyclohexane or tetrahydrofuran
  • the impregnation of the fibres with the monomer mixture is carried out, followed by optional evaporation of volatile components.
  • AU other ingredients are also incorporated into the prepreg before evaporation.
  • the viscosity of the dendrimer gel can be modified in order to keep the desired reinforcing material, like individual glass fibres, in the gel together in the thus obtained prepreg during the processing and shaping of the prepreg into the desired form.
  • the viscosity of the gel can be modified by varying the quantities of organic and inorganic fillers, or optionally varying the IPN structure of the polymeric fillers.
  • colour pigments and other conventional additives can be used in order to achieve the desired outlook and aesthetics, for example the colour of the patient's teeth.
  • the dendrimer gel, monomer mixture, dental adhesive, dental coating and preperg are curable by using preferably blue light or by auto-polymerisation, but also other curing methods can be used depending on the application.
  • AU conventional promoters, such as camphorquinone with amine catalyst can be used.
  • the polymeric nanofillers are reactively processed from solvent monomers used in processing of the highly viscous dendrimer system.
  • the reactive organic dendrimer reacts with the organic nanofiUer and the polymer chains or cluster of polymer chains of the nanofiUer which are either co- valently bound to the dendrimers or bound via interpenetrating polymer network (IPN) mechanism to the dendrimers.
  • IPN interpenetrating polymer network
  • the molecules are polymerised on molecular level within each other.
  • the reactive den- drimer reacts with the aid of or via a coupling agent(s) to yield a bond between the dendrimer and the coupling agent such as silanes or titanates, such as 3-(tri- methoxysilyl)propyl methacrylate or titanium methacrylate triisopropoxide, or the filler particles are trapped physically into the spaces between the dendrimers.
  • the fillers partially or totally penetrate into the spaces in the dendrimer structure.
  • a reactive solvent preferably an acrylate or methacrylate monomer, polymerises with the dendrimer. After polymerisation the composition may be bonded to other resins either through free radical polymerisation of dendrimers or organic fillers or via formation of IPN.
  • the introducing of a multifunctional monomer system results in large quantities of unreacted functional groups in the polymer matrix.
  • the unreacted functional groups of the polymerised and aged filling composite or FRC construction are activated at the time when adhering new liquid composite material on the aged one.
  • the polymerisation reaction forms adhesive covalent bonds between the multifunctional polymer matrix in the FRC and the newly applied composite material.
  • HBPs and dendrimers are particularly suitable in dental and medical applications.
  • the spherical shape of the molecule gives favourable rheological properties, which are advantageous when manufacturing the FRC.
  • the spherical shape and size can be tailored by selecting HBPs and dendrimers of different sizes, is it pos- sible to control the packaging of the individual components in the resin matrix used in the FRC. Further the interaction between the resin matrix and the fillers and reinforcements used in the FRCs can be enhanced by selecting a HBP or dendrimer with proper end-group functionality.
  • the wear resistance is improved by incorporating organic, inorganic, or organic-inorganic hybrid nanofiUer particles into the inter- molecular spaces between the dendrimer molecules.
  • the size of the nanoscale fillers is selected according to the intermolecular space available between the dendrimer molecules.
  • the surface of the fillers is functionalised in order to react with the functional groups of the outermost shell of the dendrimer molecules.
  • the fillers are strongly adhered and nanomechanically trapped between the dendrimer molecules, which increases considerably the wear resistance of the particulate filler composite.
  • Nanofillers made from reactive solvent mixtures, used for lowering of viscosity of dendrimers have not been disclosed in prior art. Said nanofillers are particularly important and useful as they fill intermolecular spaces available between the dendrimer molecules.
  • the dendrimer-nanofiUer composites and compositions can be used as bulk material or as a polymer matrix of FRC. Applications of fibre- reinforced composite (FRC) bridges are possible with using fibers.
  • FRC fibre- reinforced composite
  • the present invention provides the use of a reactive solvent as a carrier/former of nanofillers, and as a modifier of viscosity of the dendrimer composition system before polymerisation, which results high concentrations of dendrimers in the fi- nal compositions.
  • the multifunctional polymer composites and compositions thus obtained are suitable for dental and medical applications, filling materials, with or without reinforcement, depending on the application.
  • the multifunctional polymer composites and compositions according to the invention may be used as bulk materials or in the polymer matrix of fibre composites or particulate filler composites in applications, such as tooth filling composites, dental adhesives, dental applications, other dental technological constructions, dental and orthopedical implants, medical implants and endoprostheses, tissue guiding materials, cell and tissue culture matrix, orthopedical prostheses, drug releasing matrix materials and the like.
  • HBP-1 hyperbranched polymer with methacrylic endgroups
  • dendrimer made from pentaerythritol, 1,2,4-benzenetricarboxylic anhydride, glycidyl methacrylate and methacrylic anhydride, prepared as described in patent US 5834118
  • MMA methyl methacrylate
  • CQ camphorquinone
  • DMA EMA 2-(N,N-dimethylamino)-ethyl methacrylate
  • Disc shaped samples (diameter 5.5 mm, thickness 0.75 mm) were polymerised with blue light (400-520 nm) for 40 seconds. The degree of conversion was measured with a FTIR-spectrometer for 15 minutes after the beginning of polymerisation. The results are shown in Table 1.
  • HBP-1 dendrimer made from pentaerythritol, 1,2,4- benzenetricarboxylic anhydride, glycidyl methacrylate and methacrylic anhydride, prepared as described in patent US 5834118
  • 50 wt% of reactive monomer solvent MMA and 1 wt% of a photoinitiator accelerator mixture of example 1 were mixed together.
  • Bundles of silanized E-glassfiber rowings, coated with porous PMMA prepared as described in the patent WO96/25911) were dipped into the mixture for 5 minutes.
  • the PMMA phase on the fiber was plasticised with the dendrimer mixture, and the dendrimer-MMA mixture further impregnated the fiber bundles. Air bubbles were removed by applying vacuum. After dipping, the prepreg was slightly heated, at a temperature of 50 °C for 30 minutes. During heating, MMA evaporated from the prepreg, so that the final photocurable prepreg consisted of mainly the HBP-1 dendrimer matrix and E-glass fibers. Prepregs with larger residual amounts of MMA can also be manufactured, and the amount of MMA can be controlled by variation of the evaporation time and temperature.
  • the prepreg can be coated with a PMMA-film in a last step, by dipping it quickly into a mixture of tetrahydrofuran and PMMA (90 wt% + 10 wt%).
  • Example 5 Properties of FRC made with dendrimer matrix
  • Example 10 Shear bond test for polymer adhesion applied to ISO/TR 11405
  • the shear bonding between a dendrimer containing substrate and a commercial dental adhesive was measured according to ISO/TR 11405.
  • a dendrimer mixture composed of 80 wt% of HBP-1, 20 wt% of MMA and 1 wt% of CQ was prepared and cured a) in a light curing oven for 15 minutes, and b) using a handcuring unit for 40 s.
  • the polymerisation was done under a Mylar film in order to achieve a smooth substrate surface.
  • the surface was then threated with a commercial restorative adhesive (Sinfony Activator) for 5 min and the adherend stub was polymerised for 15 minutes in a light curing oven.
  • the results are presented in the following table 4.
  • Example 11 Use of dendrimer prepreg in the manufacture of a dental bridge
  • a RBB was made on a primary dental cast by pressing an unidirectional prepreg of example 4 against the abutment teeth surfaces after which the prepreg was light-cured.
  • the strength of the bridge can be considerably increased by an optional possibility to twist the prepreg around the distal or mesial abutment.
  • the polymerized unidirectional prepreg was then rebased with a layer of weave prepreg and light-cured.
  • the frame of the prepreg can be covered with another layer of weave prepreg.
  • the pontic teeth of the RBB were made from tooth coloured dental composite resin.
  • the RBB was luted to the etched enamel surface with normal dental luting cements.
  • Example 12 Use of a dendrimer mixture as a dental adhesive
  • Example 13 Use of a dendrimer mixture as a dental coating
  • a FRC-bridge core was manufactured using the dendrimer prepreg manufactured in example 4. After polymerisation of the FRC-bridge core, a veneering composite was used to build up the shape and colour of a teeth. The veneering composite was polymerised and a thin dendrimer layer coating was applied on the surface of the FRC-bridge. The dendrimer mixture described in example 12 was used. Tetra- hydro furan (THF) was used instead of ethanol in order to achieve a slight solva- tion of the FRC surface. THF was then evaporated from the dendrimer coating film, and the film was polymerised in a light curing oven in vacuum. A smooth scratch resistant coating was achieved.
  • THF Tetra- hydro furan
  • Example 14 Volumetric shrinkage test of manufactured FRC compositions.
  • the volumetric shrinkage was measured for three compositions, see Table 4.
  • a composition based on bisGMA was used, which was compared with two compositions based on hyperbranched polymers HBP-1 and HBP -2.
  • HBP-1 is a dendrimer made from pentaerythritol, 1,2,4-benzenetricarboxylic anhydride, glycidyl methacrylate and methacrylic anhydride
  • HBP-2 is a dendrimer made from pentaerythritol, 1,2,4-benzenetricarboxylic anhydride, glycidyl methacrylate and acetic anhydride, both prepared as described in patent US 5834118.
  • the volumetric shrinkage was measured according to ASTM 792.
  • the FRC compositions were polymerised using a handcuring unit Optilux for 40 sec, additionally were duplicate samples postpolymerised using a LicuLite light curing oven for 15 min.
  • HBP-1 is a dendrimer made from pentaerythritol, 1,2,4-benzenetricarboxylic anhydride, glycidyl methacrylate and methacrylic anhydride
  • HBP-2 is a dendrimer made from pentaerythritol, 1,2,4-benzenetricarboxylic anhydride, glycidyl methacrylate and acetic anhydride, both prepared as described in patent US 5834118.
  • the density was measured according to ASTM 792.
  • the FRC compositions were polymerised using a handcuring unit Optilux for 40 sec, additionally were duplicate samples postpolymerised using a LicuLite light curing oven for 15 min.
  • a polymerised with handcuring unit Optilux 40 sec and postpolymerisation in a LicuLite light curing oven for 15 min.
  • the polymerisation was done using Optilux handcuring unit for 40, 60 and 120 sec, see Table 7.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Composite Materials (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • General Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Transplantation (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Birds (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PCT/FI2002/000087 2001-02-06 2002-02-06 Dental and medical polymer composites and compositions Ceased WO2002062901A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2002231823A AU2002231823B2 (en) 2001-02-06 2002-02-06 Dental and medical polymer composites and compositions
CNB028059034A CN100393813C (zh) 2001-02-06 2002-02-06 牙用和医用聚合物复合材料和组合物
PL365346A PL204442B1 (pl) 2001-02-06 2002-02-06 Polimeryzowalny wielofunkcyjny kompozyt polimerowy i kompozycja polimerowa, sposób wytwarzania takiego kompozytu lub kompozycji i ich zastosowanie
CA2437622A CA2437622C (en) 2001-02-06 2002-02-06 Dental and medical polymer composites and compositions
BRPI0207480-0A BR0207480B1 (pt) 2001-02-06 2002-02-06 composto ou composição polimérico multifincional polimerizável, método para manufaturar e uso de um composto ou composição polimérico multifuncional polimerizável.
US10/467,080 US7354969B2 (en) 2001-02-06 2002-02-06 Dental and medical polymer composites and compositions
KR1020037010390A KR100893126B1 (ko) 2001-02-06 2002-02-06 치과용 및 의료용 폴리머 복합체들 및 조성물들
DE60228823T DE60228823D1 (de) 2001-02-06 2002-02-06 Zahnmedizinische und medizinische polymerverbunde und zusammensetzungen
EP02711891A EP1368430B1 (en) 2001-02-06 2002-02-06 Dental and medical polymer composites and compositions
JP2002563245A JP3971307B2 (ja) 2001-02-06 2002-02-06 歯科用及び医療用重合性組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26647601P 2001-02-06 2001-02-06
FI20010222A FI20010222A0 (fi) 2001-02-06 2001-02-06 Lääketieteellisesti hammashoidolliset polymeerikomposiitit ja -koostumukset
US60/266,476 2001-02-06
FI20010222 2001-02-06

Publications (2)

Publication Number Publication Date
WO2002062901A1 true WO2002062901A1 (en) 2002-08-15
WO2002062901A8 WO2002062901A8 (en) 2003-11-13

Family

ID=26161119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2002/000087 Ceased WO2002062901A1 (en) 2001-02-06 2002-02-06 Dental and medical polymer composites and compositions

Country Status (12)

Country Link
EP (1) EP1368430B1 (enExample)
JP (1) JP3971307B2 (enExample)
KR (1) KR100893126B1 (enExample)
CN (1) CN100393813C (enExample)
AT (1) ATE407976T1 (enExample)
AU (1) AU2002231823B2 (enExample)
BR (1) BR0207480B1 (enExample)
CA (1) CA2437622C (enExample)
DE (1) DE60228823D1 (enExample)
ES (1) ES2312554T3 (enExample)
PL (1) PL204442B1 (enExample)
WO (1) WO2002062901A1 (enExample)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005092986A1 (ja) * 2004-03-25 2008-02-14 東洋紡績株式会社 樹脂組成物
EP2145613A1 (de) 2008-07-02 2010-01-20 Ernst Mühlbauer GmbH & Co.KG Infiltrant für die Dentalapplikation
EP2153812A1 (de) 2008-08-13 2010-02-17 Ernst Mühlbauer GmbH & Co.KG Röntgenopaker Infiltrant
DE202009016522U1 (de) 2009-11-24 2010-03-04 Ernst Mühlbauer Gmbh & Co. Kg Infiltrant zur Behandlung einer Zahnschmelzläsion
WO2010108863A1 (de) 2009-03-24 2010-09-30 Basf Se Strahlungshärtbare hochfunktionelle polyurethan(meth)acrylate
EP1954748A4 (en) * 2005-11-30 2011-11-30 Ashland Licensing & Intellectu PREPREGS AND SOLID CREATED SOLID SURFACES
US8362172B2 (en) 2009-03-06 2013-01-29 Ernst Muhlbauer Gmbh & Co. Kg Infiltrant for dental application
US8851891B2 (en) 2008-11-06 2014-10-07 Zimmer Dental, Inc. Expandable bone implant
US8899981B2 (en) 2005-08-30 2014-12-02 Zimmer Dental, Inc. Dental implant for a jaw with reduced bone volume and improved osseointegration features
US9066771B2 (en) 2008-07-02 2015-06-30 Zimmer Dental, Inc. Modular implant with secured porous portion
US9095396B2 (en) 2008-07-02 2015-08-04 Zimmer Dental, Inc. Porous implant with non-porous threads
US9439738B2 (en) 2009-11-24 2016-09-13 Zimmer Dental, Inc. Porous implant device with improved core
WO2017014443A1 (ko) * 2015-07-22 2017-01-26 주식회사 쿠보텍 민어 부레의 접착성분을 함유하는 치과용 본드
US9707058B2 (en) 2009-07-10 2017-07-18 Zimmer Dental, Inc. Patient-specific implants with improved osseointegration

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005018451B4 (de) * 2005-04-20 2008-07-24 Heraeus Kulzer Gmbh Verwendung von dendritischen Verbindungen in Dentalmaterialien
US9149345B2 (en) 2007-08-30 2015-10-06 Zimmer Dental, Inc. Multiple root implant
US8899982B2 (en) 2008-07-02 2014-12-02 Zimmer Dental, Inc. Implant with structure for securing a porous portion
JP2010126569A (ja) * 2008-11-26 2010-06-10 Hakuto Co Ltd 感光性樹脂組成物
CN102643500B (zh) * 2012-04-01 2013-12-04 哈尔滨工业大学 有机-无机纳米复合树脂及其制备方法
JP6035073B2 (ja) * 2012-07-25 2016-11-30 株式会社トクヤマデンタル 歯科用硬化性組成物
JP6055227B2 (ja) * 2012-08-03 2016-12-27 株式会社トクヤマデンタル 歯科用常温重合レジン
JP5991880B2 (ja) * 2012-08-10 2016-09-14 株式会社トクヤマデンタル 粉液型歯科用接着材およびこれを用いた歯科用接着キット
JP6124533B2 (ja) * 2012-08-20 2017-05-10 株式会社トクヤマデンタル 歯科用セメントキット
DE102012016418B4 (de) * 2012-08-21 2024-04-25 Kulzer Gmbh Dentaler Haftvermittler für Hochleistungspolymere
CN103948516A (zh) * 2014-05-19 2014-07-30 北京化工大学常州先进材料研究院 一种齿科修复用光固化复合树脂及其制备方法
JP6667554B2 (ja) * 2015-12-28 2020-03-18 ヤマハ株式会社 Frp用樹脂組成物、frpシート及び成形体
CN107537061B (zh) * 2016-06-23 2019-11-22 辽宁爱尔创生物材料有限公司 一种牙科用复合树脂材料的制备方法及其制备的产品
CN109431817A (zh) * 2018-12-20 2019-03-08 四川华柚医疗器械有限公司 一种新型树脂牙及其制作方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024831A1 (en) * 1996-12-04 1998-06-11 Dentsply International Inc. Epoxide-amine dendrimers and the preparation and use thereof
WO1998036729A1 (en) * 1997-02-21 1998-08-27 Dentsply International Inc. Low shrinking polymerizable dental material
WO1999009934A2 (de) * 1997-08-22 1999-03-04 Espe Dental Ag Härtbare masse mit silan-dendrimeren
US5886064A (en) * 1994-12-08 1999-03-23 Ivoclar Ag Fine-grained polymerizable compositions flowable under pressure or shear stress
WO1999045890A1 (en) * 1998-03-09 1999-09-16 Stick Tech Oy A novel prepreg

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886064A (en) * 1994-12-08 1999-03-23 Ivoclar Ag Fine-grained polymerizable compositions flowable under pressure or shear stress
WO1998024831A1 (en) * 1996-12-04 1998-06-11 Dentsply International Inc. Epoxide-amine dendrimers and the preparation and use thereof
WO1998036729A1 (en) * 1997-02-21 1998-08-27 Dentsply International Inc. Low shrinking polymerizable dental material
WO1999009934A2 (de) * 1997-08-22 1999-03-04 Espe Dental Ag Härtbare masse mit silan-dendrimeren
WO1999045890A1 (en) * 1998-03-09 1999-09-16 Stick Tech Oy A novel prepreg

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005092986A1 (ja) * 2004-03-25 2008-02-14 東洋紡績株式会社 樹脂組成物
JP5018084B2 (ja) * 2004-03-25 2012-09-05 東洋紡績株式会社 樹脂組成物
US10070945B2 (en) 2005-08-30 2018-09-11 Zimmer Dental, Inc. Dental implant for a jaw with reduced bone volume and improved osseointegration features
US8899981B2 (en) 2005-08-30 2014-12-02 Zimmer Dental, Inc. Dental implant for a jaw with reduced bone volume and improved osseointegration features
EP1954748A4 (en) * 2005-11-30 2011-11-30 Ashland Licensing & Intellectu PREPREGS AND SOLID CREATED SOLID SURFACES
EP2151229A2 (de) 2008-07-02 2010-02-10 Ernst Mühlbauer GmbH & Co.KG Infiltrant für die Dentalapplikation
EP2145613A1 (de) 2008-07-02 2010-01-20 Ernst Mühlbauer GmbH & Co.KG Infiltrant für die Dentalapplikation
US9095396B2 (en) 2008-07-02 2015-08-04 Zimmer Dental, Inc. Porous implant with non-porous threads
US9066771B2 (en) 2008-07-02 2015-06-30 Zimmer Dental, Inc. Modular implant with secured porous portion
EP2548546A1 (de) 2008-08-13 2013-01-23 Ernst Mühlbauer GmbH & Co.KG Röntgenopaker Infiltrant
US8183305B2 (en) 2008-08-13 2012-05-22 Ernst Muhlbauer Gmbh & Co. Kg Radiopaque infiltrant
EP2153812A1 (de) 2008-08-13 2010-02-17 Ernst Mühlbauer GmbH & Co.KG Röntgenopaker Infiltrant
US8851891B2 (en) 2008-11-06 2014-10-07 Zimmer Dental, Inc. Expandable bone implant
US9744007B2 (en) 2008-11-06 2017-08-29 Zimmer Dental, Inc. Expandable bone implant
US9211236B2 (en) 2009-03-06 2015-12-15 Muhlbauer Gmbh & Co. Kg Infiltrant for dental application
US8362172B2 (en) 2009-03-06 2013-01-29 Ernst Muhlbauer Gmbh & Co. Kg Infiltrant for dental application
US9200108B2 (en) 2009-03-24 2015-12-01 Basf Se Radiation-curing, highly functional polyurethane (meth)acrylate
WO2010108863A1 (de) 2009-03-24 2010-09-30 Basf Se Strahlungshärtbare hochfunktionelle polyurethan(meth)acrylate
US9707058B2 (en) 2009-07-10 2017-07-18 Zimmer Dental, Inc. Patient-specific implants with improved osseointegration
US9439738B2 (en) 2009-11-24 2016-09-13 Zimmer Dental, Inc. Porous implant device with improved core
US9901424B2 (en) 2009-11-24 2018-02-27 Zimmer Dental, Inc. Porous implant device with improved core
DE202009016522U1 (de) 2009-11-24 2010-03-04 Ernst Mühlbauer Gmbh & Co. Kg Infiltrant zur Behandlung einer Zahnschmelzläsion
US10687919B2 (en) 2009-11-24 2020-06-23 Zimmer Dental, Inc. Porous implant device with improved core
WO2017014443A1 (ko) * 2015-07-22 2017-01-26 주식회사 쿠보텍 민어 부레의 접착성분을 함유하는 치과용 본드

Also Published As

Publication number Publication date
BR0207480A (pt) 2004-08-10
PL204442B1 (pl) 2010-01-29
ES2312554T3 (es) 2009-03-01
EP1368430B1 (en) 2008-09-10
WO2002062901A8 (en) 2003-11-13
JP3971307B2 (ja) 2007-09-05
CN1643073A (zh) 2005-07-20
CA2437622A1 (en) 2002-08-15
EP1368430A1 (en) 2003-12-10
CN100393813C (zh) 2008-06-11
PL365346A1 (en) 2004-12-27
JP2004525216A (ja) 2004-08-19
BR0207480B1 (pt) 2011-12-13
KR100893126B1 (ko) 2009-04-10
KR20040011460A (ko) 2004-02-05
CA2437622C (en) 2011-05-31
DE60228823D1 (de) 2008-10-23
ATE407976T1 (de) 2008-09-15
AU2002231823B2 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
US7354969B2 (en) Dental and medical polymer composites and compositions
AU2002231823B2 (en) Dental and medical polymer composites and compositions
AU2002231823A1 (en) Dental and medical polymer composites and compositions
JP2702694B2 (ja) 圧縮応力または剪断応力下で流動性の微粒化重合性組成物
CN101489518B (zh) 纤维增强的复合材料及其制备方法
CA2656864C (en) Fiber-reinforced dental composites and method for the manufacture thereof
CN111228124B (zh) 快速固化和低收缩应力的可光聚合牙科复合材料
CN1175897A (zh) 聚合物-纤维预浸物,其制备方法及其应用
JP2016513071A (ja) 付加開裂オリゴマー
El-Banna et al. Resin-based dental composites for tooth filling
JP2017095478A (ja) 置換糖化合物及び歯科用組成物
US20070043142A1 (en) Dental compositions based on nanofiber reinforcement
JP2002515048A (ja) 金属酸化物組成物及び方法
KR20240005107A (ko) 치과 재료를 제조하기 위한 단량체 혼합물
US8956629B2 (en) Dental composition containing organic nanotube
CN106420366A (zh) 一种超低收缩复合树脂及其制备方法
WO2003013379A2 (en) Dental compositions
JP2004525220A (ja) 金属高分子複合体用接着剤
Watts Orthodontic adhesive resins and composites: principles of adhesion
WO2023163676A1 (en) Production of antibacterial and regenerative dental composites using supportive phases with improved antibacterial and bioactive properties
Sun et al. Development of novel low shrinkage dental nanocomposite

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002711891

Country of ref document: EP

Ref document number: 2002563245

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2437622

Country of ref document: CA

Ref document number: 1020037010390

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2002231823

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 028059034

Country of ref document: CN

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 33/2002 DUE TO A TECHNICAL PROBLEM AT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION.

Free format text: IN PCT GAZETTE 33/2002 DUE TO A TECHNICAL PROBLEM AT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION.

WWP Wipo information: published in national office

Ref document number: 2002711891

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10467080

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1020037010390

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 2002711891

Country of ref document: EP